Last reviewed · How we verify

ESP Catheter — Competitive Intelligence Brief

ESP Catheter (ESP Catheter) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cardiac ablation catheter. Area: Cardiology.

marketed Cardiac ablation catheter Cardiology Small molecule Live · refreshed every 30 min

Target snapshot

ESP Catheter (ESP Catheter) — University of Minnesota. The ESP Catheter is an electrosurgical ablation device that uses radiofrequency energy to create lesions in cardiac tissue for arrhythmia treatment.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ESP Catheter TARGET ESP Catheter University of Minnesota marketed Cardiac ablation catheter

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cardiac ablation catheter class)

  1. University of Minnesota · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ESP Catheter — Competitive Intelligence Brief. https://druglandscape.com/ci/esp-catheter. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: